Page last updated: 2024-08-23

buserelin and Lung Neoplasms

buserelin has been researched along with Lung Neoplasms in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-199011 (50.00)18.7374
1990's10 (45.45)18.2507
2000's0 (0.00)29.6817
2010's1 (4.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S1
Kido, M; Kodate, M; Nagata, N; Nikaido, Y; Shirakusa, T; Tao, Y; Tsuda, T; Yoshii, C1
de Voogt, H; Denis, L; Sylvester, RJ1
Kiesel, L; van Groeninghen, JC; Winkler, D; Zwirner, M1
Broux, R; Corhay, JL; Limet, R; Radermecker, M1
Balbi, B; Lantero, S; Oddera, S; Ravazzoni, C; Rossi, GA1
Baldelli, S; Cellerino, R; Menichetti, ET; Miseria, S; Murer, B; Torresi, U; Tummarello, D1
Borlée, G; Broux, R; Bury, T; Corhay, JL; Gaspard, U; Gustin, M; Limet, R; Noël, F; Radermecker, MA; Saint-Remy, P1
Armengol, J; Bella, F; Calaf, J; Espaulella, J; Lain, JM1
Blamey, RW; Griffiths, K; Pearson, D; Turkes, A; Williams, MR2
Heyman, J; Leiter, E1
Castoldi, R; Di Carlo, V; Di Palo, S; Mari, G; Staudacher, C; Taccagni, G1
Dal Bo, V; Della Valentina, M; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Monfardini, S; Talamini, R; Veronesi, A1
Huhtaniemi, I; Kauppila, A; Martikainen, H; Penttinen, J1
Argüelles, AE; Lascano, A; Poggi, U; Volmer, MC1
Nicholson, RI; Plowman, PN; Walker, KJ1
Blamey, RW; Robertson, JF1
Abdulwahid, NA; Craft, I; Hague, WM; Jacobs, HS1
Falkson, G; Vorobiof, DA1
Ackman, CF; Koutsilieris, M1
Farid, NR; Jean, C; Maheux, R; Parent, JG; Samson, Y1

Trials

1 trial(s) available for buserelin and Lung Neoplasms

ArticleYear
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
    European urology, 1998, Volume: 33, Issue:2

    Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate

1998

Other Studies

21 other study(ies) available for buserelin and Lung Neoplasms

ArticleYear
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
    World journal of urology, 2015, Volume: 33, Issue:6

    Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2015
[Two cases of pulmonary lymphangioleiomyomatosis].
    Nihon Kyobu Shikkan Gakkai zasshi, 1993, Volume: 31, Issue:9

    Topics: Adult; Buserelin; Female; Humans; Lung; Lung Neoplasms; Lymphangioleiomyomatosis; Progesterone; Recurrence

1993
Effects of luteinising-hormone-releasing hormone on nervous-system tumours.
    Lancet (London, England), 1998, Aug-01, Volume: 352, Issue:9125

    Topics: Brain; Brain Neoplasms; Buserelin; Carcinoma, Squamous Cell; Chordoma; Glioblastoma; Glioma; Gonadotropin-Releasing Hormone; Humans; Iodine Radioisotopes; Lung Neoplasms; Meningioma; Progesterone; Radiopharmaceuticals; Receptors, LHRH; Receptors, Progesterone; Spinal Cord Neoplasms

1998
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients.
    Chest, 1992, Volume: 101, Issue:6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pneumothorax; Recurrence; Tamoxifen

1992
Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.
    The American review of respiratory disease, 1991, Volume: 143, Issue:1

    Topics: Adult; Buserelin; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Lung; Lung Neoplasms; Lymphangiomyoma; Progesterone; Radiography; Testosterone

1991
Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
    Tumori, 1991, Feb-28, Volume: 77, Issue:1

    Topics: Buserelin; Carcinoma; Flutamide; Goserelin; Humans; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Prostatic Neoplasms

1991
[Apropos of 2 cases of lymphangiomyomatosis treated with LH-RH agonists].
    Revue medicale de Liege, 1991, Volume: 46, Issue:5

    Topics: Adult; Antineoplastic Agents; Buserelin; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Tomography, X-Ray Computed

1991
Pulmonary endometriosis: conservative treatment with GnRH agonists.
    Obstetrics and gynecology, 1991, Volume: 78, Issue:3 Pt 2

    Topics: Administration, Intranasal; Adult; Antineoplastic Agents; Buserelin; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hemoptysis; Hormones; Humans; Leuprolide; Lung Neoplasms; Pneumothorax; Triptorelin Pamoate

1991
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data.
    British journal of cancer, 1990, Volume: 61, Issue:1

    Topics: Biomarkers, Tumor; Blood Sedimentation; Bone Neoplasms; Breast Neoplasms; Buserelin; C-Reactive Protein; Carcinoembryonic Antigen; Female; Ferritins; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Orosomucoid; Ovariectomy; Tamoxifen

1990
Serum ferritin as a marker of therapeutic response in stage III and IV breast cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1990, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Ferritins; Follow-Up Studies; Goserelin; Humans; Lung Neoplasms; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Remission Induction; Retrospective Studies; Tamoxifen

1990
Dramatic response of pulmonary metastasis from prostatic cancer to LH-RH agonist treatment.
    The Mount Sinai journal of medicine, New York, 1989, Volume: 56, Issue:2

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Buserelin; Gonadotropin-Releasing Hormone; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Rectal Diseases; Ulcer

1989
Endometriosis of the lung.
    Respiratory medicine, 1989, Volume: 83, Issue:3

    Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Humans; Lung; Lung Neoplasms; Radiography, Thoracic

1989
Buserelin treatment of advanced prostatic cancer: a phase II study.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4

    Topics: Aged; Bone Neoplasms; Buserelin; Drug Evaluation; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Remission Induction

1989
Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy.
    Gynecologic oncology, 1989, Volume: 35, Issue:3

    Topics: Bone Neoplasms; Buserelin; Female; Goserelin; Granulosa Cell Tumor; Humans; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Pituitary Hormone-Releasing Hormones

1989
Lung metastases of prostate carcinoma cleared by intranasal GRH analogue.
    Lancet (London, England), 1985, Jun-29, Volume: 1, Issue:8444

    Topics: Adenocarcinoma; Administration, Intranasal; Aged; Buserelin; Humans; Lung Neoplasms; Male; Prostatic Neoplasms

1985
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
    British journal of cancer, 1986, Volume: 54, Issue:6

    Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction

1986
Response in post-menopausal patients on ICI 118630.
    British journal of cancer, 1987, Volume: 55, Issue:4

    Topics: Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Lung Neoplasms; Middle Aged

1987
Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma.
    British journal of obstetrics and gynaecology, 1986, Volume: 93, Issue:5

    Topics: Adult; Buserelin; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Ovary; Uterine Neoplasms

1986
Nasally administered buserelin inducing complete remission of lung metastases in male breast cancer.
    Cancer, 1987, Feb-15, Volume: 59, Issue:4

    Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Humans; Lung Neoplasms; Male; Middle Aged

1987
Complete response of lung metastases caused by prostatic cancer after chronic administration of a gonadotropin-releasing hormone analog, buserelin (HOE 766).
    The Prostate, 1987, Volume: 10, Issue:1

    Topics: Adenocarcinoma; Aged; Buserelin; Humans; Lung; Lung Neoplasms; Male; Prostatic Neoplasms; Radiography

1987
Utilization of luteinizing hormone-releasing hormone agonist in pulmonary leiomyomatosis.
    Fertility and sterility, 1987, Volume: 48, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Buserelin; Dyspnea; Estradiol; Female; Humans; Leiomyoma; Lung Neoplasms; Ovariectomy; Pain; Uterine Neoplasms

1987